Evaluating the Indirect Costs of Care Associated with Salvage Chemotherapy for Relapsed and Refractory Aggressive-Histology Lymphoma: A Subset Analysis of the Canadian Cancer Trials Group (CCTG) LY.12 Clinical Trial

We conducted an analysis of indirect costs alongside the LY.12 randomized trial in patients with relapsed or refractory (R/R) aggressive non-Hodgkin lymphoma (NHL). Lost productivity data for Canadian patients and caregivers in the trial were collected at baseline and with each chemotherapy cycle pr...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Curr Oncol
Main Authors: Prica, Anca, Hay, Annette E., Crump, Michael, Mittmann, Nicole, Shepherd, Lois E., Meyer, Ralph M., Imrie, Kevin I., Risebrough, Nancy, Djurfeldt, Marina, Chen, Bingshu E., Cheung, Matthew C.
Formato: Artigo
Idioma:Inglês
Publicado em: MDPI 2021
Assuntos:
Brief Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8025821/
https://ncbi.nlm.nih.gov/pubmed/33802634
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/curroncol28020119
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados